Pathologies we can check

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pericardial fat
learn more
Whole Body
Head & Torso
Torso
Heart and Great Vessels
Perivascular space
learn more
Head & Torso
Whole Body
Brain
Pheochromocytoma
learn more
Head & Torso
Torso
Whole Body
Adrenals
Phrygian cap
learn more
Whole Body
Head & Torso
Torso
Gallbladder and Biliary System
Pineal Cyst
learn more
Head & Torso
Whole Body
Brain
Pituitary mass
learn more
Head & Torso
Whole Body
Brain
Pleural effusion
learn more
Whole Body
Head & Torso
Torso
Lungs and Mediastinum
Polycystic kidney disease
learn more
Head & Torso
Whole Body
Torso
Kidneys
Polycystic liver disease
learn more
Head & Torso
Torso
Whole Body
Liver
Polycystic ovary
learn more
Head & Torso
Whole Body
Torso
Ovaries
Polysplenia
learn more
Head & Torso
Whole Body
Torso
Spleen
Prior fracture of the sacroilliac joint
learn more
Head & Torso
Whole Body
Torso
Sacroiliac Joints
Prostate abscess
learn more
Head & Torso
Whole Body
Prostate
Prostate cancer
learn more
Head & Torso
Whole Body
Prostate
Prostate cyst
learn more
Head & Torso
Whole Body
Prostate
Prostate visibility
learn more
Head & Torso
Whole Body
Prostate
Prostatitis
learn more
Head & Torso
Whole Body
Prostate
Proteinaceous cyst
learn more
Whole Body
Head & Torso
Torso
Kidneys
Reactive or inflammatory lymph nodes of the neck
learn more
Head & Torso
Whole Body
Cervical Lymph Node Chain
Recent fracture of the sacroilliac joint
learn more
Head & Torso
Whole Body
Torso
Sacroiliac Joints

Take a quick quiz to assess your cancer risk

*The Prenuvo whole-body MRI screening:

The Prenuvo whole-body MRI screening: (1) can serve as an adjunct to, but is not intended to replace, other established evidence–based screening practices for early detection of specific malignancies (e.g. colonoscopy, dedicated breast imaging, Pap-smear screening for cervical cancer, low-dose chest CT for high risk patients), (2) may not detect some very small cancers that happen to have an MRI appearance very similar to nearby normal tissue structures. We can generally identify cancerous lesions once they are approximately one centimeter in size, although the size limit of detection varies and may be lower in some parts of the body (e.g. the brain) and higher in other parts (e.g. the chest). Our method may not detect lesions in the lining tissue (mucosa) of various body parts, including the mouth, nose, throat, and gastrointestinal tract. As with any medical test, there are limitations, which make it impossible to detect all malignancies and disease conditions, (3)t does not evaluate the heart or heart vessels, (5) does not evaluate detailed lung microarchitecture or pulmonary micronodules, (6) does not replace dedicated breast imaging for screening or diagnostic evaluation (e.g. mammography, breast ultrasound, breast MRI with contrast), (7) is limited in the evaluation of the gastrointestinal tract and does not replace endoscopy or colonoscopy (e.g. cannot detect gastrointestinal polyps), (8) is limited in its assessment of the large joints as the exam is not tailored for detailed evaluation of the joint ligaments, cartilage, menisci, and labrum, (9) should not be considered a primary screening modality of the skin – this is best assessed by direct physical examination, (10) does not visualize smaller brain vessels – as with any imaging test, there are limitations, and stenosis or certain blood flow abnormalities may not be detected, (11) is not intended to replace dedicated diagnostic imaging in the setting of specific clinical diagnostic questions.

Open modal